Two Sigma Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.4M Buy
3,700
+700
+23% +$710K ﹤0.01% 2334
2025
Q4
$3.22M Buy
3,000
+1,000
+50% +$956K ﹤0.01% 2089
2025
Q3
$1.53M Buy
+2,000
New +$1.49M ﹤0.01% 2311
2022
Q1
Sell
-10,400
Closed -$2.87M 3578
2021
Q4
$2.87M Buy
10,400
+6,300
+154% +$1.6M 0.01% 1605
2021
Q3
$947K Sell
4,100
-6,200
-60% -$1.53M ﹤0.01% 2663
2021
Q2
$2.36M Buy
10,300
+6,100
+145% +$1.23M 0.01% 1734
2021
Q1
$785K Sell
4,200
-3,000
-42% -$587K ﹤0.01% 2533
2020
Q4
$1.22M Buy
+7,200
New +$1.08M ﹤0.01% 1851
2020
Q3
Sell
-2,000
Closed -$328K 3347
2020
Q2
$328K Sell
2,000
-2,500
-56% -$384K ﹤0.01% 2315
2020
Q1
$624K Sell
4,500
-9,100
-67% -$1.25M 0.01% 1770
2019
Q4
$1.79M Sell
13,600
-7,500
-36% -$869K 0.01% 1680
2019
Q3
$2.36M Sell
21,100
-56,500
-73% -$6.29M 0.01% 1300
2019
Q2
$8.6M Buy
77,600
+17,600
+29% +$2.07M 0.03% 660
2019
Q1
$7.79M Buy
60,000
+51,600
+614% +$6.27M 0.03% 769
2018
Q4
$972K Sell
8,400
-23,000
-73% -$2.57M ﹤0.01% 1673
2018
Q3
$3.37M Sell
31,400
-72,200
-70% -$7.22M 0.01% 1142
2018
Q2
$8.84M Buy
103,600
+56,100
+118% +$4.61M 0.03% 718
2018
Q1
$3.67M Buy
47,500
+37,200
+361% +$2.99M 0.01% 1132
2017
Q4
$870K Sell
10,300
-28,200
-73% -$2.4M ﹤0.01% 2058
2017
Q3
$3.29M Buy
+38,500
New +$3.16M 0.01% 1020
2017
Q1
Sell
-261,600
Closed -$19.2M 3129
2016
Q4
$19.2M Buy
261,600
+95,400
+57% +$7.1M 0.07% 323
2016
Q3
$13.3M Buy
166,200
+113,200
+214% +$9.06M 0.05% 439
2016
Q2
$4.17M Buy
53,000
+49,000
+1,225% +$3.69M 0.02% 846
2016
Q1
$288K Buy
4,000
+1,000
+33% +$75.7K ﹤0.01% 2404
2015
Q4
$253K Buy
+3,000
New +$249K ﹤0.01% 2342

Other funds holding LLY

Two Sigma Investments's LLY Position: Q1 2026 in Review

Two Sigma Investments increased its Eli Lilly (LLY) stake by 394% in Q1 2026, buying an estimated $52.2M and bringing the position to 64,550 shares worth $59.4M. The position accounts for 0.05% of the portfolio, ranked #430.

Two Sigma Investments first reported a position in LLY in Q2 2013 and has held it in 35 quarters since. The position peaked at $249M in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Two Sigma Investments held 64,550 shares of Eli Lilly worth $59.4M as of Q1 2026.
  • Two Sigma Investments bought 51,482 Eli Lilly shares in Q1 2026, an estimated $52.2M.
  • Eli Lilly made up 0.05% of Two Sigma Investments's portfolio in Q1 2026, its #430 holding.
  • Two Sigma Investments first reported a position in Eli Lilly in Q2 2013 and has held it in 35 quarters since.
  • Two Sigma Investments's Eli Lilly position peaked at $249M in Q4 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.